Cargando…
Investigation of SARS-CoV-2 RNAemia in the convalescent plasma of COVID-19 patients
PURPOSE: The novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is responsible for the ongoing global COVID-19 disease pandemic. Convalescent plasma therapy (CPT) is one of the promising therapies being tried for COVID-19 patients. However, the presence or disappearance of SARS-CoV-...
Autores principales: | Perumal, N., Jain, R.K., Chaurasia, D., Sharma, U.M., Malik, R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier Ltd.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8884820/ http://dx.doi.org/10.1016/j.ijid.2021.12.089 |
Ejemplares similares
-
RETRACTED: Treatment with Ivermectin Is Associated with
Decreased Mortality in COVID-19 Patients: Analysis of a National Federated
Database
por: Efimenko, I., et al.
Publicado: (2022) -
Utilité de la plasmathérapie de convalescents dans le traitement de formes prolongées d'infection à SARS-CoV-2 chez des patients immunodéprimés.
por: Drumel, T., et al.
Publicado: (2023) -
Estimating SARS-CoV-2 prevalence from large-scale wastewater surveillance: insights from combined analysis of 44 sites in England
por: Morvan, M., et al.
Publicado: (2022) -
Assessment of High-Titer Convalescent Plasma as an Adjunctive Therapy in the Reduction of Mortality Rate and Viral Load in Patients with Severe COVID-19: A Meta-Analysis
por: Ramos, M.M., et al.
Publicado: (2022) -
Emerging COVID-associated Mucor-Aspergillosis – A Need of Separate Definition
por: Singh, V., et al.
Publicado: (2022)